oncology

You have access
The National Oncology PET Registry (NOPR): A monumental effort by a few leaders
Johannes Czernin

Journal of Nuclear Medicine January 25, 2018, jnumed.118.207860; DOI: https://doi.org/10.2967/jnumed.118.207860
You have access
Analysis of Prognostic Values of Various PET Metrics in Preoperative ¹⁸F-FDG PET for Early-Stage Bronchial Carcinoma for Progression-Free and Overall Survival: Significantly Increased Glycolysis Is a Predictive Factor
Seraina Steiger, Michael Arvanitakis, Beate Sick, Walter Weder, Sven Hillinger and Irene A. Burger

Journal of Nuclear Medicine December 1, 2017, 58 (12) 1925-1930; DOI: https://doi.org/10.2967/jnumed.117.189894
You have access
Current Concepts in ⁶⁸Ga-DOTATATE Imaging of Neuroendocrine Neoplasms: Interpretation, Biodistribution, Dosimetry, and Molecular Strategies
Lisa Bodei, Valentina Ambrosini, Ken Herrmann and Irvin Modlin

Journal of Nuclear Medicine November 1, 2017, 58 (11) 1718-1726; DOI: https://doi.org/10.2967/jnumed.116.186361
You have access
In Vivo Quantification of ERβ Expression by Pharmacokinetic Modeling: Studies with ¹⁸F-FHNP PET
Inês F. Antunes, Antoon T.M. Willemsen, Jurgen W.A. Sijbesma, Ate S. Boerema, Aren van Waarde, Andor W.J.M. Glaudemans, Rudi A.J.O. Dierckx, Elisabeth G.E. de Vries, Geke A.P. Hospers and Erik F.J. de Vries

Journal of Nuclear Medicine November 1, 2017, 58 (11) 1743-1748; DOI: https://doi.org/10.2967/jnumed.117.192666
You have access
Simulation of Tracer Dose Reduction in ¹⁸F-FDG PET/MRI: Effects on Oncologic Reading, Image Quality, and Artifacts
Ferdinand Seith, Holger Schmidt, Julia Kunz, Thomas Küstner, Sergios Gatidis, Konstantin Nikolaou, Christian la Fougère and Nina Schwenzer

Journal of Nuclear Medicine October 1, 2017, 58 (10) 1699-1705; DOI: https://doi.org/10.2967/jnumed.116.184440
You have access
Theranostics Using Antibodies and Antibody-Related Therapeutics
Kirsten L. Moek, Danique Giesen, Iris C. Kok, Derk Jan A. de Groot, Mathilde Jalving, Rudolf S.N. Fehrmann, Marjolijn N. Lub-de Hooge, Adrienne H. Brouwers and Elisabeth G.E. de Vries

Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 83S-90S; DOI: https://doi.org/10.2967/jnumed.116.186940
You have access
Proof of Therapeutic Efficacy of a ¹⁷⁷Lu-Labeled Neurotensin Receptor 1 Antagonist in a Colon Carcinoma Xenograft Model
Jörg Schulz, Martin Rohracker, Marvin Stiebler, Jürgen Goldschmidt, Franziska Stöber, Mercedes Noriega, Anette Pethe, Mathias Lukas, Frank Osterkamp, Ulrich Reineke, Aileen Höhne, Christiane Smerling and Holger Amthauer

Journal of Nuclear Medicine June 1, 2017, 58 (6) 936-941; DOI: https://doi.org/10.2967/jnumed.116.185140
You have access
Comparison of Empiric Versus Whole-Body/-Blood Clearance Dosimetry–Based Approach to Radioactive Iodine Treatment in Patients with Metastases from Differentiated Thyroid Cancer
Désirée Deandreis, Carole Rubino, Hernan Tala, Sophie Leboulleux, Marie Terroir, Eric Baudin, Steve Larson, James A. Fagin, Martin Schlumberger and R. Michael Tuttle

Journal of Nuclear Medicine May 1, 2017, 58 (5) 717-722; DOI: https://doi.org/10.2967/jnumed.116.179606
You have access
The Impact of Somatostatin Receptor–Directed PET/CT on the Management of Patients with Neuroendocrine Tumor: A Systematic Review and Meta-Analysis
Martin Barrio, Johannes Czernin, Stefano Fanti, Valentina Ambrosini, Ina Binse, Lin Du, Matthias Eiber, Ken Herrmann and Wolfgang P. Fendler

Journal of Nuclear Medicine May 1, 2017, 58 (5) 756-761; DOI: https://doi.org/10.2967/jnumed.116.185587
You have access
Safety, Dosimetry, and Tumor Detection Ability of ⁶⁸Ga-NOTA-AE105: First-in-Human Study of a Novel Radioligand for uPAR PET Imaging
Dorthe Skovgaard, Morten Persson, Malene Brandt-Larsen, Camilla Christensen, Jacob Madsen, Thomas Levin Klausen, Søren Holm, Flemming Littrup Andersen, Annika Loft, Anne Kiil Berthelsen, Helle Pappot, Klaus Brasso, Niels Kroman, Liselotte Højgaard and Andreas Kjaer

Journal of Nuclear Medicine March 1, 2017, 58 (3) 379-386; DOI: https://doi.org/10.2967/jnumed.116.178970

Main menu

User menu

Search

oncology

Pages